Peroxynitrite decomposition catalyst FeTMPyP provides partial protection against intestinal ischemia and reperfusion

Giorgio Stefanutti1, Agostino Pierro, Virpi V Smith

  • 1Units of Paediatric Surgery, Institute of Child Health, London, WC1N 1EH, United Kingdom.

Pediatric Research
|May 23, 2007
PubMed

Insights

Peroxynitrite decomposition catalyst FeTMPyP offers limited protection against infant intestinal ischemia-reperfusion (I/R) injury. It reduced inflammation and oxidative stress in the ileum and lungs, preserving antioxidant capacity in neonatal rats.

Area of Science:

  • Biomedical Science
  • Gastroenterology
  • Pediatric Research

Background:

  • Free radicals contribute significantly to intestinal ischemia-reperfusion (I/R) injury, causing damage to both the intestines and lungs.
  • Understanding the role of reactive oxygen species in I/R injury is crucial for developing therapeutic strategies, especially in vulnerable infant populations.

Purpose of the Study:

  • To evaluate the protective effects of the peroxynitrite decomposition catalyst, FeTMPyP, against intestinal I/R injury in a neonatal rat model.
  • To investigate the impact of FeTMPyP on key markers of inflammation, oxidative stress, and antioxidant capacity following I/R.

Main Methods:

  • Suckling rats were subjected to 40 minutes of intestinal ischemia followed by 90 minutes of reperfusion.
  • Animals received either saline or FeTMPyP at the onset of reperfusion.
  • Histological injury, ICAM-1, P-selectin, myeloperoxidase, malondialdehyde, and glutathione levels were assessed in the ileum and lungs.

Main Results:

  • FeTMPyP administration reduced P-selectin expression, neutrophil infiltration (myeloperoxidase), and lipid peroxidation (malondialdehyde) in the ileum.
  • While glutathione levels were decreased in all I/R groups, FeTMPyP treatment led to higher oxidized and total glutathione compared to saline.
  • Systemic nitric oxide production (nitrate+nitrite) was elevated in the saline group but not in the FeTMPyP group.

Conclusions:

  • FeTMPyP demonstrates limited protective efficacy in neonatal rat intestinal I/R injury.
  • The compound mitigates I/R-induced damage by decreasing P-selectin expression, systemic nitric oxide, neutrophil infiltration, and lipid peroxidation.
  • FeTMPyP helps preserve intestinal antioxidant capacity, suggesting a potential role in managing I/R-related complications in infants.

Related Concept Videos